Clinics in Dermatology
Volume 26, Issue 3 , Pages 243-254 , May 2008

Cutaneous manifestations of cardiovascular diseases

References 

  1. Moreillon P, Yok-Ai Q. Infective endocarditis. Lancet. 2004;363:139–149
  2. Hogevik H, Olaison L, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an urban population: a 5-year prospective study. Medicine (Baltimore). 1995;74:324–339
  3. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318–1330
  4. Murtagh B, Frazier OH, Letsou GV. Diagnosis and management of bacterial endocarditis in 2003. Curr Opin Cardiol. 2003;18:106–110
  5. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638
  6. Larbalestier RI, Kinchla NM, Aranki SF, et al. Acute bacterial endocarditis: optimizing surgical results. Circulation. 1992;86:II 68–II 74
  7. Denny FW, Wannamaker LW, Brink WR, et al. Prevention of rheumatic fever. Treatment of the preceding streptococcal infection. JAMA. 1950;143:151–153
  8. Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991;10:S25–S27
  9. Van de Rijn I, Zabriskie JB, McCarty M. Group A streptococcal antigens cross-reactive with myocardium: purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med. 1977;146:579–599
  10. Cunningham MW, McCormack JM, Talaber LR, et al. Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol. 1988;141:2760–2766
  11. Stollerman H. Rheumatic fever. Lancet. 1997;349:935–942
  12. Jones TD. The diagnosis of acute rheumatic fever. JAMA. 1944;126:481–484
  13. Special Writing Group of the Committee on Rheumatic Fever. Guidelines for the diagnosis of acute rheumatic fever: Jones criteria, 1992 update. JAMA. 1992;268:2069–2073
  14. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine. 1995;74:1–12
  15. American Academy of Pediatrics . Group A streptococcal infections. In:  Pickering LK editors. Report of the Committee on Infectious Diseases. Illinois: American Academy of Pediatrics; 2003;p. 573–583
  16. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96:758–764
  17. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987;38:769–784
  18. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. 2003;42:211–216
  19. Doty JR, Wilentz RE, Salazar JD, et al. Atheroembolism in cardiac surgery. Ann Thorac Surg. 2003;75:1221
  20. Baumann DS, McGraw D, Rubin BG, et al. An institutional experience with arterial atheroembolism. Ann Vasc Surg. 1994;8:258–265
  21. Tunick PA, Nayar AC, Goodkin GM, et al. for the NYU Atheroma Group Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90:1320–1325
  22. Mann SJ, Sos TA. Treatment of atheroembolism with corticosteroids. Am J Hypertens. 2001;14:831–834
  23. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ. 2002;324:268–269
  24. Russo GG. Hyperlipidemias. Clin Dermatol. 1996;14:367–374
  25. Cardiovascular diseases. In:  Lebwohl M editors. The skin and systemic disease. London: Churchill Livingston; 2004;p. 43–57
  26. Parker F. Xanthomas and hyperlipidemias. J Am Acad Dermatol. 1985;13:1–30
  27. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047–2060
  28. Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41:127–132
  29. Kyle RA. Amyloidosis. Circulation. 1995;91:1269–1271
  30. Vander Salm TJ. Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg. 2000;12:89–100
  31. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001;80:159–172
  32. Garcia-F-Villata MJ, Sanz-Sanchez T, Aragues M, et al. Cutaneous embolization of cardiac myxoma. Br J Dermatol. 2002;147:379–382
  33. Yuehua L, Jing G, Hongwei W, et al. Left atrial myxoma presenting with erythematous macules and loss of memory. Clin Exp Dermatol. 2003;28:383–386
  34. Wilkes D, McDermott DA, Basson CT. Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol. 2005;6:501–508
  35. Gorlin RJ, Anderson RC, Blaw M. Multiple lentigines syndrome. Am J Dis Child. 1969;117:652–662
  36. Legius E, Schrander-Stumpel C, Schollen E, et al. PTPN11 mutations in LEOPARD syndrome. J Med Genet. 2002;39:571–574
  37. Fryer PR, Pope FM. Accumulation of membrane-bound melanosomes occurs in Langerhans cells of patients with the Leopard syndrome. Clin Exp Dermatol. 1992;17:13–15
  38. Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome: case report and review of literature. Am J Med. 1976;60:447–456
  39. Sutton MGSJ, Tajik AJ, Giuliani ER, et al. Hypertrophic obstructive cardiomyopathy and lentiginosis: a little known neural ectodermal syndrome. Am J Cardiol. 1981;47:214–217
  40. Walther RJ, Polansky BJ, Grots IA. Electrocardiographic abnormalities in lentigo. N Engl J Med. 1966;275:1220–1225
  41. Matthews MD. Lentigo and electrocardiographic changes. N Engl J Med. 1968;278:780–781
  42. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy. 1967;16:178–222
  43. Burns JC. Translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J. 2002;21:993–995
  44. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the US. Pediatr Res. 1974;8:427A
  45. Taubert KA, Rowley AH, Schulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr. 1991;119:279–282
  46. Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364:533–544
  47. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1988 in Japan. Pediatrics. 2001;107:E33–E36
  48. Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol. 1997;6:181–185
  49. Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology. 2005;16:220–225
  50. Brown TJ, Crawford SE, Cornwall M, et al. CD8+ cells and macrophages infiltrate coronary artery aneurysms in Kawasaki disease. J Infect Dis. 2001;184:940–994
  51. Rowley AH, Echerley CA, Jack HM, et al. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol. 1997;159:5946–5955
  52. Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 2001;166:1334–1343
  53. Morens DM, O'Brian RJ. Kawasaki disease in the United States. J Infect Dis. 1978;137:91–93
  54. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776–1780
  55. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–2771
  56. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–1639
  57. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1,100 cases. Pediatr Cardiol. 1986;7:3–9
  58. Kurisu Y, Azumi T, Sugahara T, et al. Variation in coronary arterial dimension (distension abnormality) after disappearing aneurysm in Kawasaki disease. Am Heart J. 1987;114:532–538
  59. Sigamura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994;89:258–265
  60. Suzuki A, Yamagishi M, Kimura K, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol. 1996;27:291–296
  61. Burns JC, Shike H, Gordon JB, et al. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol. 1996;28:253–257
  62. Klein BS, Rogers MF, Patrican LA, et al. Kawasaki syndrome: a controlled study of an outbreak in Wisconsin. Am J Epidemiol. 1986;124:306–316
  63. Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev. 1988;9:209–217
  64. Akagi T, Kato H, Inoue O, et al. Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J. 1990;120:366–372
  65. Kato H, Sugimura T, Agaki T, et al. Long-term consequences of Kawasaki disease: 10-21 year follow-up study of 594 patients. Circulation. 1996;1379–1385
  66. Ringpfeil F, Lebwohl M, Christiano AM, et al. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette [ABC] transporter. Proc Natl Acad Sci U S A. 2000;97:6001–6006
  67. Sherer D, Bercovitch L, Lebwohl M. Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol. 2001;44:534–537
  68. Pope FM. Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum. Br J Dermatol. 1975;92:493–509
  69. Gheduzzi D, Sammarco R, Quaglino D. Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum. Ultrastruct Pathol. 2003;27:375–384
  70. Lebwohl M, Distefano D, Prioleau PG, et al. Pseudoxanthoma elasticum and mitral valve prolapse. N Engl J Med. 1982;228–231
  71. Navarro-Lopez F, Llorian A, Ferrer-Roca O, et al. Restrictive cardiomyopathy in pseudoxanthoma elasticum. Chest. 1980;78:113–115
  72. Abdelmalek NF, Gerber TL, Menter A. Cardiocutaneous syndromes and associations. J Am Acad Dermatol. 2002;161–183
  73. Hu X, Plomp AS, Van Soest S, et al. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol. 2003;48:424–438
  74. Lebwohl M, Nelder K, Pope FM, et al. Classification of pseudoxanthoma elasticum: report of a consensus conference. J Am Acad Dermatol. 1994;30:103–107
  75. Lebwohl M, Halperin J, Phelps R. Occult pseudoxanthoma elasticum in patients with premature cardiovascular disease. N Engl J Med. 1993;329:1237–1239
  76. George S, Jacob M, Pulimood S, Chandi SM. Cutis laxa. Clin Exp Dermatol. 1998;23:211–213
  77. Beighton P. The dominant and recessive forms of cutis laxa. J Med Genet. 1972;9:216–221
  78. Weir EK, Joffe HS, Blaufuss AH, et al. Cardiovascular abnormalities in cutis laxa. Eur J Cardiol. 1977;5:255–261
  79. Stahle E, Tammelin A, Bergstrom R, et al. Sternal wound complications: incidence, microbiology and risk factors. Eur J Cardiothorac Surg. 1997;11:1146–1153
  80. Utley JR, Thomason ME, Wallace DJ, et al. Preoperative correlates of impaired wound healing after saphenous vein excision. J Thorac Cardiovasc Surg. 1989;98:147–149
  81. Karakas M, Baba M, Aksungur VL, et al. Manifestation of cellulitis after saphenous venectomy for coronary bypass surgery. Eur Acad Dermatol Venereol. 2002;16:438–440
  82. Carr RD, Rau RC. Dermatitis at vein graft site in coronary artery bypass patients. Arch Dermatol. 1981;117:814–815
  83. Frank ST. Aural sign of coronary artery disease. N Engl J Med. 1973;289:327–328
  84. Brady PM, Zive MA, Goldberg RJ, et al. A new wrinkle to the earlobe crease. Arch Int Med. 1987;147:65–66
  85. Cheng TO. Earlobe crease and coronary artery disease: association or coincidence?. Am J Med. 1992;93:587–598
  86. Miric D, Fabijanic D, Giunio L, et al. Dermatological indicators of coronary risk: a case-control study. Int J Cardiol. 1998;67:251–255
  87. Petrakis NL. Earlobe crease in women: evaluation of reproductive factors, alcohol use, Quetelet index and relation to atherosclerotic disease. Am J Med. 1995;99:356–361
  88. Elliot W, Powell L. Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease. Am J Med. 1996;100:205–211
  89. Tranchesi B, Barbosa V, Piva de Albuquerque C, et al. Diagonal earlobe crease as a marker of the presence and extent of coronary atherosclerosis. Am J Cardiol. 1992;70:1417–1420
  90. Shoenfeld Y, Mor R, Weinberger A, et al. Diagonal ear lobe crease and coronary risk factors. J Am Geriatr Soc. 1980;27:184–187
  91. Pe'er J, Vidaurri J, Halfon ST, et al. Association between corneal arcus and some of the risk factors for coronary artery disease. Br J Ophthalmol. 1983;67:795–798
  92. Ewing JA, Rouse BA. Corneal arcus as a sign of possible alcoholism. Alcohol Clin Exp Res. 1980;4:104–106
  93. Chua BE, Mitchell P, Wang JJ, et al. Corneal arcus and hyperlipidemia: findings from an older population. Am J Ophthalmol. 2004;137:363–365
  94. Winder AF, Jolleys JC, Day LB, et al. Corneal arcus, case finding and definition of individual clinical risk in heterozygous familial hypercholesterolaemia. Clin Genet. 1998;54:497–502
  95. Hoogerbrugge N, Happee C, Van Domburg R, et al. Corneal arcus: indicator for severity of coronary atherosclerosis. Neth J Med. 1999;55:184–187
  96. Chambless LE, Fuchs FD, Linn S, et al. The association of corneal arcus with coronary disease and cardiovascular mortality in the lipid research clinics mortality follow-up study. Am J Public Health. 1990;80:1200–1204

PII: S0738-081X(07)00237-4

doi: 10.1016/j.clindermatol.2007.10.014

Clinics in Dermatology
Volume 26, Issue 3 , Pages 243-254 , May 2008

Article Tools

* Image Usage & Resolution